Chloe is a research associate in the Sabeti Lab investigating RNA-targeting CRISPR antiviral therapies, which have huge potential for the treatment of RNA viral diseases like influenza and Lassa virus. She uses Illumina sequencing and other cutting-edge technologies to track viral evolution in response to antiviral treatment.
She graduated from Tufts University in 2018 with a B.S. in Biology and Community Health. There, she conducted research on a variety of vaccine development programs, both at the Singapore Immunology Network and Massachusetts General Hospital. She also investigated Chagas disease risk and transmission in Costa Rican rainforests.
Chloe is dedicated to alleviating health disparities on a local and global scale, and aspires to be an infectious disease physician. While not in lab, she volunteers as an income tax preparer at Boston Medical Center, tends to her houseplants, and tries to keep her crossword puzzle streak alive.